Company / Debt per Share
BridgeBio Pharma, Inc. Debt per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$10.56
FY2025
5-year range
$2.50 / $10.56
FY2021-FY2025
Trend
+322.9%
vs FY2024
Sector context
#26 of 82
Health Care
What the data says
Debt per Share changed +323% YoY in FY2025, a notable deviation from the 7-year average annual change of +92%.
Based on SEC 10-K filings.
10.56 in FY2025 with a 5-year CAGR of +69.3%.
Increased from $2.96 to $10.56 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +53.4%
- 5-Year CAGR
- +69.3%
- 10-Year CAGR
- -
Sector benchmark
#57 of 82 in Health CareTop 68% of 82This company $10.56 Sector average $126.59
▼
-91.7% below sector average
Key checks
Key Insights
- In FY2025, debt per share increased 322.9% year-over-year.
- Ranks #26 out of 82 companies in the Health Care sector.
- Lowest debt per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.56 | +322.9% |
| FY2024 | $2.50 | -15.7% |
| FY2023 | $2.96 | +1.3% |
| FY2022 | $2.93 | -16.6% |
| FY2021 | $3.51 | +361.9% |
| FY2020 | $0.76 | -26.7% |
| FY2019 | $1.04 | +17.4% |
| FY2018 | $0.88 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026